AAAAAA

   
Results: 1-8 |
Results: 8
EFFECT OF FOOD ON THE BIOAVAILABILITY OF TRICLABENDAZOLE IN PATIENTS WITH FASCIOLIASIS
Authors: LECAILLON JB GODBILLON J CAMPESTRINI J NAQUIRA C MIRANDA L PACHECO R MULL R POLTERA AA
Citation: Jb. Lecaillon et al., EFFECT OF FOOD ON THE BIOAVAILABILITY OF TRICLABENDAZOLE IN PATIENTS WITH FASCIOLIASIS, British journal of clinical pharmacology, 45(6), 1998, pp. 601-604
THE INFLUENCE OF FOOD ON THE DISPOSITION OF THE ANTIEPILEPTIC RUFINAMIDE IN HEALTHY-VOLUNTEERS
Authors: CARDOT JM LECAILLON JB CZENDLIK C GODBILLON J
Citation: Jm. Cardot et al., THE INFLUENCE OF FOOD ON THE DISPOSITION OF THE ANTIEPILEPTIC RUFINAMIDE IN HEALTHY-VOLUNTEERS, Biopharmaceutics & drug disposition, 19(4), 1998, pp. 259-262
AUTOMATED AND SENSITIVE METHOD FOR THE DETERMINATION OF FORMOTEROL INHUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND ELECTROCHEMICAL DETECTION
Authors: CAMPESTRINI J LECAILLON JB GODBILLON J
Citation: J. Campestrini et al., AUTOMATED AND SENSITIVE METHOD FOR THE DETERMINATION OF FORMOTEROL INHUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND ELECTROCHEMICAL DETECTION, Journal of chromatography B. Biomedical sciences and applications, 704(1-2), 1997, pp. 221-229
BIOEQUIVALENCE ASSESSMENT - A PHARMACEUTICAL-INDUSTRY PERSPECTIVE
Authors: GODBILLON J CARDOT JM LECAILLON JB LEFEVRE G SIOUFI A
Citation: J. Godbillon et al., BIOEQUIVALENCE ASSESSMENT - A PHARMACEUTICAL-INDUSTRY PERSPECTIVE, European journal of drug metabolism and pharmacokinetics, 21(2), 1996, pp. 153-158
AUTOMATED-ANALYSIS OF A NOVEL ANTIEPILEPTIC COMPOUND, CGP-33-101, ANDITS METABOLITE, CGP-47-292, IN BODY-FLUIDS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND LIQUID-SOLID EXTRACTION
Authors: ROUAN MC SOUPPART C ALIF L MOES D LECAILLON JB GODBILLON J
Citation: Mc. Rouan et al., AUTOMATED-ANALYSIS OF A NOVEL ANTIEPILEPTIC COMPOUND, CGP-33-101, ANDITS METABOLITE, CGP-47-292, IN BODY-FLUIDS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND LIQUID-SOLID EXTRACTION, Journal of chromatography B. Biomedical applications, 667(2), 1995, pp. 307-313
SINGLE-CENTER, OPEN-LABEL, PLACEBO-CONTROLLED TRIAL TO DETERMINE THE EFFECTS OF 900 MG OXCARBAZEPINE TWICE-DAILY ON MARKERS OF ENZYME-INDUCTION IN HEALTHY MALE-VOLUNTEERS
Authors: BROOKMAN LJ LLOYD P LECAILLON JB EZZET F ROUTLEDGE PA SCHWABE S
Citation: Lj. Brookman et al., SINGLE-CENTER, OPEN-LABEL, PLACEBO-CONTROLLED TRIAL TO DETERMINE THE EFFECTS OF 900 MG OXCARBAZEPINE TWICE-DAILY ON MARKERS OF ENZYME-INDUCTION IN HEALTHY MALE-VOLUNTEERS, Epilepsia, 36, 1995, pp. 161-161
AUTOMATED MICROANALYSIS OF OXCARBAZEPINE AND ITS MONOHYDROXY AND TRANSDIOL METABOLITES IN PLASMA BY LIQUID-CHROMATOGRAPHY
Authors: ROUAN MC DECHERF M LECLANCHE V LECAILLON JB GODBILLON J
Citation: Mc. Rouan et al., AUTOMATED MICROANALYSIS OF OXCARBAZEPINE AND ITS MONOHYDROXY AND TRANSDIOL METABOLITES IN PLASMA BY LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 658(1), 1994, pp. 167-172
THE EFFECT OF RENAL IMPAIRMENT ON THE PHARMACOKINETICS OF OXCARBAZEPINE AND ITS METABOLITES
Authors: ROUAN MC LECAILLON JB GODBILLON J MENARD F DARRAGON T MEYER P KOURILSKY O HILLION D ALDIGIER JC JUNGERS P
Citation: Mc. Rouan et al., THE EFFECT OF RENAL IMPAIRMENT ON THE PHARMACOKINETICS OF OXCARBAZEPINE AND ITS METABOLITES, European Journal of Clinical Pharmacology, 47(2), 1994, pp. 161-167
Risultati: 1-8 |